Simplex Trading’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Simplex Trading’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,492	Closed	-$242K	–	11023
2021 Q1	$222K	Buy	9,492 +8,030	+549%	+$243K	﹤0.01%	4600
2020 Q4	$42K	Buy	+1,462	New	+$36.8K	﹤0.01%	6379
2020 Q3	–	Sell	-23	Closed	-$562	–	8867
2020 Q2	$0	Sell	23 -543	-96%	-$19.6K	﹤0.01%	8714
2020 Q1	$17K	Buy	566 +453	+401%	+$15.7K	﹤0.01%	6109
2019 Q4	$5K	Buy	+113	New	+$3.26K	﹤0.01%	6736

Simplex Trading's CNST Position: Q2 2021 in Review

Simplex Trading sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 9,492 shares — an estimated $242K sold.

Simplex Trading first reported a position in CNST in Q4 2019 and held it in 5 quarters. The position peaked at $222K in Q1 2021. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

Simplex Trading reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Simplex Trading sold 9,492 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $242K.
Simplex Trading first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 5 quarters.
Simplex Trading's Constellation Pharmaceuticals, Inc. position peaked at $222K in Q1 2021.
153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.